GRIMES & Co WEALTH MANAGEMENT, LLC Q2 2023 Filing

Filed July 19, 2023

Portfolio Value

$2.8T

Holdings

315

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (315 positions)

#StockSharesValue% PortfolioType
301
MERSANA THERAPEUTICS INC
15,740$51.8M0.00%
302
VORVOR BIOPHARMA INC
13,622$42.1M0.00%
303
ASNSUSDX4 PHARMACEUTICALS INC
15,000$29.1M0.00%
304
PSN 0.25 08/15/25PARSONS CORP DEL
25,000$28.6M0.00%
305
RBBNRIBBON COMMUNICATIONS INC
10,030$28.0M0.00%
306
IBRXIMMUNITYBIO INC
10,000$27.8M0.00%
307
VSH 2.25 06/15/25VISHAY INTERTECHNOLOGY INC
20,000$21.9M0.00%
308
FUBOFUBOTV INC
10,000$20.8M0.00%
309
APOLLO COML REAL ESTATE FIN
20,000$19.8M0.00%
310
AYX 0.5 08/01/24ALTERYX INC
20,000$18.8M0.00%
311
ONSGBPOUTLOOK THERAPEUTICS INC
10,000$17.4M0.00%
312
RGLSREGULUS THERAPEUTICS INC
10,363$15.2M0.00%
313
ARCC 4.625 03/01/24ARES CAPITAL CORP
15,000$15.0M0.00%
314
VIAV 1 03/01/24VIAVI SOLUTIONS INC
10,000$9.9M0.00%
315
GWRE 1.25 03/15/25GUIDEWIRE SOFTWARE INC
10,000$9.6M0.00%
PreviousPage 4 of 4